{"id":"W4402868174","doi":"10.1002/ajh.27487","title":"Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Dell Medical School, University of Texas at Austin; Terumo BCT; U.S. Food and Drug Administration; National Institutes of Health; Grifols; McGovern Medical School; Vanderbilt University Medical Center; Omeros Corporation; Swedish Orphan Biovitrum; University of Texas at Austin; Janssen Pharmaceuticals; Vanderbilt University; Gilead Sciences; Momenta Pharmaceuticals; Sanofi; AstraZeneca; Amgen","keywords":"Neonatal Fc receptor; Medicine; Immunology; Antibody; Immune system; Adverse effect; Hematology; Thrombocytopenic purpura; Immunoglobulin G; Clinical trial; In vivo; Pharmacology; Biology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007236369,0.0008371725,0.001279855,0.002461392,0.0002434633,0.0009315046,0.001002853,0.0009990718,0.004400219],"category_scores_gemma":[0.0009129446,0.0002755871,0.000730862,0.001846638,0.0003439498,0.001062827,0.0005609377,0.001660719,0.001642281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004944197,"about_ca_system_score_gemma":0.0008740636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008427575,"about_ca_topic_score_gemma":0.001501842,"domain_scores_codex":[0.9998173,0.00003540668,0.00003188806,0.0000269053,0.00007030454,0.00001812687],"domain_scores_gemma":[0.9996259,0.0002089555,0.00005286308,0.000009618089,0.00007310908,0.00002942363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001095826,0.00008829815,0.0001393888,0.02022903,0.0001180622,0.0001630822,0.00005691543,0.0003529467,0.001124541,0.002503763,0.0226606,0.9524538],"study_design_scores_gemma":[0.00004911708,0.0001287424,0.0007806699,0.006139338,0.0002785835,0.001214814,0.00006009526,0.0001405779,0.0005072489,0.001817419,0.9888656,0.00001787607],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008705679,0.9989997,0.0000574871,0.0001481975,0.0001054414,0.000003790572,0.0000103522,0.000005005679,0.0005830086],"genre_scores_gemma":[0.000448195,0.9988632,0.0001169532,0.0001368341,0.0001050324,0.000006065489,0.00002236878,0.000001120997,0.0003001095],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004400219,"threshold_uncertainty_score":0.0147202,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01407092375757604,"score_gpt":0.3413138708524309,"score_spread":0.3272429470948549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}